[A16-67] Macitentan (pulmonary arterial hypertension) - Benefit assessment according to §35a Social Code Book V
Last updated 16.01.2017
Project no.:
A16-67
Commission:
Commission awarded on 13.10.2016 by the Federal Joint Committee (G-BA).
Report type:
Dossier assessment
Status:
Commission completed
Department/Division:
Drug Assessment
Application field:
Heart and circulation
Note:
After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.
| Project no. | Title | Status |
|---|---|---|
| G14-01 | Macitentan - Assessment according to §35a (para. 1., sentence 10) Social Code Book V (dossier assessment) | Commission completed |